Clinical Trial Update: Study to Evaluate the Efficacy and Safety of ZL-3101 in Subjects With Subacute Eczema [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ZL-3101 for subacute eczema has completed. The study was sponsored by Zai Lab Pty. Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ZL-3101

Snippet

Sponsor: Zai Lab Pty. Ltd. | Conditions: Eczema | Phase 2 | Status: COMPLETED